← Founder Notes
Archive

The pharmaceutical pipeline now has an ai cohort

Yethikrishna ROriginal on Threads

the pharmaceutical pipeline now has an ai cohort: more than 173 ai-discovered drug programs are in clinical trials, with 15 in phase iii, and no fully ai-designed drug has passed approval yet. a multi-agent system showed a 184x speedup over single-agent curation.

the question is no longer whether ai finds molecules, but who takes the liability when one fails a trial.

Context

Medspark (Jul 19, 2026) says more than 173 AI-originated drug programs were in clinical development as of early 2026, and AiDrugDev's pipeline page says 173+ programs are in trials as of mid-2026 with no fully AI-discovered drug yet approved by the FDA.

IssueByte (Apr 8, 2026) says more than 15 AI-designed candidates have entered Phase III trials.

How it compares

The 173 programs, about 15 in Phase III and no approved fully AI-designed drug match the pages read. The 184x speedup from a multi-agent system was not seen in the sources read, so unsupported here, not refuted. The nearest source read, an arXiv paper on multi-agent dataset curation (2610.07075), is a different topic. The liability question is the post's framing.

Related work

Watch next

  • Find the study behind the 184x multi-agent speedup.

Sources

  1. Medspark, Jul 19, 2026medspark.ai
  2. AiDrugDev pipelineaidrugdev.com
  3. IssueByte, Apr 8, 2026issuebyte.com

Provenance

The note above is reproduced unedited from the original post, first published on Threads on 2 October 2026 at 01:16 IST. Sources are the papers and datasets the note draws on.

View the original post
Embed this note
<iframe src="https://founder.myndlabs.tech/notes/embed/the-pharmaceutical-pipeline-now-has-an-ai-cohort-Dd9sahHld00" width="480" height="420" style="border:0;max-width:100%" loading="lazy" title="The pharmaceutical pipeline now has an ai cohort"></iframe>

More notes